Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
CENTRAL STIMULATION OF RENIN SECRETION THROUGH SEROTONERGIC, NONCARDIOVASCULAR MECHANISMS
Autore:
RITTENHOUSE PA; BAKKUM EA; LEVY AD; LI Q; YRACHETA JM; KUNIMOTO K; VANDEKAR LD;
Indirizzi:
LOYOLA UNIV,MED CTR,DEPT PHARMACOL,2160 S FIRST AVE MAYWOOD IL 60153 LOYOLA UNIV,MED CTR,DEPT PHARMACOL MAYWOOD IL 60153 LOYOLA UNIV,STRITCH SCH MED,DEPT PHARMACOL MAYWOOD IL 60153
Titolo Testata:
Neuroendocrinology
fascicolo: 2, volume: 60, anno: 1994,
pagine: 205 - 214
SICI:
0028-3835(1994)60:2<205:CSORST>2.0.ZU;2-N
Fonte:
ISI
Lingua:
ENG
Soggetto:
PARAVENTRICULAR NUCLEUS MEDIATE; CENTRAL-NERVOUS-SYSTEM; PARA-CHLOROAMPHETAMINE; CORTICOSTERONE SECRETION; PHARMACOLOGICAL EVIDENCE; RECEPTOR AGONIST; 5-HT2 RECEPTORS; WATER-EXCRETION; CONSCIOUS RATS; RELEASE;
Keywords:
SEROTONIN; SEROTONIN RECEPTORS; SEROTONIN RECEPTOR ANTAGONISTS; P-CHLOROAMPHETAMINE; RU 24969; BLOOD PRESSURE; HEART RATE; PRAZOSIN; LY53857; DOPAMINE; DOPAMINE ANTAGONISTS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
46
Recensione:
Indirizzi per estratti:
Citazione:
P.A. Rittenhouse et al., "CENTRAL STIMULATION OF RENIN SECRETION THROUGH SEROTONERGIC, NONCARDIOVASCULAR MECHANISMS", Neuroendocrinology, 60(2), 1994, pp. 205-214

Abstract

The aims of the study were to determine; (1) whether activation of serotonin (5-HT) receptors in the brain increases renin secretion, and (2) whether the hypertensive effects of a 5-HT agonist and 5-HT releaser obscure their ability to stimulate renin release. Various drugs thatincrease serotonergic neuro-transmission can activate the secretion of renin from the kidneys. Many of these drugs can also elevate blood pressure. Changes in blood pressure can alter renin secretion by activating renal baroreceptor mechanisms, so that a decrease in profusion pressure will increase renin secretion and vice versa. To address the first objective, the 5-HT agonist RU 24969 (0, 10, 100 and 200 mu g/kg) and the 5-HT releaser p-chloroamphetamine (0, 50, 500 and 1,000 mu g/kg) were injected intracerebroventriculary (ICV) at doses lower than those that are peripherally effective. ICV injection of RU 24969 dose-dependently increased plasma levels of renin. ICV injection of the 5-HT2A/5-HT2C antagonist LY53857 (50 mu g/kg)inhibited the renin response to peripherally injected RU 24969 (0, 1, 5 and 10 mg/kg i.p.), suggesting that 5-HT2A/5-HT2C receptors in the brain mediate the effect of peripherally injected RU 24969 on renin secretion. In contrast, ICV injection of p-chloroamphetamine decreased renin secretion. To determine whether hypertensive actions could account for the differences between RU 24969 and p-chloroamphetamine, we measured the effects of both p-choloroamphetamine and RU 24969 on blood pressure and heart rate. ICV injection of p-chloroamphetamine (1,000 mu g/kg) produced a large rise of44 mm Hg at 2 min and 25 mm Hg at 5 min after injection, while ICV injection of RU 24969 (200 mu/kg) caused a slower and smaller blood pressure elevation of 18 mm Hg at 5 min after injection. To determine whether the hypertensive effects of both RU 24969 and p-chloroamphetamine could mask their effects on renin secretion, rats were pretreated withthe alpha(1) antagonist prazosin. Administration of prazosin (1 mg/kgs.c), which prevents the hypertensive effects of p-chloroamphetamine,exposed a stimulatory effect of ICV-injected p-chloroamphetamine (500mu g/kg) on renin secretion and potentiated the effect of RU 24969 (5mg/kg i.p.) on renin release. In conclusion, these data suggest that both RU 24969 and p-chloroamphetamine increase renin secretion throughcentral 5-HT receptors, and that these effects are partially obscuredby their hypertensive actions.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/11/20 alle ore 07:10:49